nodes	percent_of_prediction	percent_of_DWPC	metapath
Spironolactone—AR—hematologic cancer	0.116	0.499	CbGaD
Spironolactone—NR3C1—hematologic cancer	0.0785	0.338	CbGaD
Spironolactone—ABCB1—hematologic cancer	0.0379	0.163	CbGaD
Spironolactone—NR3C2—Betamethasone—hematologic cancer	0.0302	0.0924	CbGbCtD
Spironolactone—NR3C2—Prednisolone—hematologic cancer	0.0297	0.0912	CbGbCtD
Spironolactone—SLCO1A2—Chlorambucil—hematologic cancer	0.0224	0.0686	CbGbCtD
Spironolactone—PGR—Betamethasone—hematologic cancer	0.0195	0.0597	CbGbCtD
Spironolactone—NR3C2—Dexamethasone—hematologic cancer	0.0175	0.0538	CbGbCtD
Spironolactone—Potassium Canrenoate—Prednisone—hematologic cancer	0.0136	0.052	CrCrCtD
Spironolactone—Potassium Canrenoate—Prednisolone—hematologic cancer	0.0132	0.0508	CrCrCtD
Spironolactone—ABCC2—Daunorubicin—hematologic cancer	0.0131	0.0402	CbGbCtD
Spironolactone—NR3C1—Triamcinolone—hematologic cancer	0.0116	0.0355	CbGbCtD
Spironolactone—PGR—Dexamethasone—hematologic cancer	0.0113	0.0347	CbGbCtD
Spironolactone—Testolactone—Dexamethasone—hematologic cancer	0.0101	0.0387	CrCrCtD
Spironolactone—Testolactone—Betamethasone—hematologic cancer	0.0101	0.0387	CrCrCtD
Spironolactone—Hydrocortamate—Prednisone—hematologic cancer	0.00996	0.0382	CrCrCtD
Spironolactone—NR3C1—Betamethasone—hematologic cancer	0.00995	0.0305	CbGbCtD
Spironolactone—Testolactone—Triamcinolone—hematologic cancer	0.00987	0.0379	CrCrCtD
Spironolactone—NR3C1—Prednisolone—hematologic cancer	0.00981	0.0301	CbGbCtD
Spironolactone—Hydrocortamate—Prednisolone—hematologic cancer	0.00972	0.0373	CrCrCtD
Spironolactone—Cortisone acetate—Prednisone—hematologic cancer	0.00965	0.037	CrCrCtD
Spironolactone—Cortisone acetate—Prednisolone—hematologic cancer	0.00942	0.0361	CrCrCtD
Spironolactone—Testolactone—Prednisone—hematologic cancer	0.00937	0.0359	CrCrCtD
Spironolactone—Fluoxymesterone—Betamethasone—hematologic cancer	0.00928	0.0356	CrCrCtD
Spironolactone—Fluoxymesterone—Dexamethasone—hematologic cancer	0.00928	0.0356	CrCrCtD
Spironolactone—NR3C1—Prednisone—hematologic cancer	0.00927	0.0284	CbGbCtD
Spironolactone—Testolactone—Prednisolone—hematologic cancer	0.00914	0.0351	CrCrCtD
Spironolactone—Fluoxymesterone—Triamcinolone—hematologic cancer	0.00907	0.0348	CrCrCtD
Spironolactone—Fludrocortisone—Dexamethasone—hematologic cancer	0.00904	0.0347	CrCrCtD
Spironolactone—Fludrocortisone—Betamethasone—hematologic cancer	0.00904	0.0347	CrCrCtD
Spironolactone—Fludrocortisone—Triamcinolone—hematologic cancer	0.00884	0.0339	CrCrCtD
Spironolactone—SLCO1A2—Prednisolone—hematologic cancer	0.00846	0.0259	CbGbCtD
Spironolactone—Fluoxymesterone—Prednisolone—hematologic cancer	0.0084	0.0322	CrCrCtD
Spironolactone—Fludrocortisone—Prednisone—hematologic cancer	0.00839	0.0322	CrCrCtD
Spironolactone—Fludrocortisone—Prednisolone—hematologic cancer	0.00819	0.0314	CrCrCtD
Spironolactone—Progesterone—Prednisolone—hematologic cancer	0.00819	0.0314	CrCrCtD
Spironolactone—Methyltestosterone—Prednisone—hematologic cancer	0.00818	0.0314	CrCrCtD
Spironolactone—SLCO1A2—Prednisone—hematologic cancer	0.00799	0.0245	CbGbCtD
Spironolactone—Methyltestosterone—Prednisolone—hematologic cancer	0.00798	0.0306	CrCrCtD
Spironolactone—Hydrocortisone—Dexamethasone—hematologic cancer	0.00738	0.0283	CrCrCtD
Spironolactone—Hydrocortisone—Betamethasone—hematologic cancer	0.00738	0.0283	CrCrCtD
Spironolactone—ABCB1—Lenalidomide—hematologic cancer	0.00729	0.0224	CbGbCtD
Spironolactone—Hydrocortisone—Triamcinolone—hematologic cancer	0.00721	0.0276	CrCrCtD
Spironolactone—Testosterone—Prednisolone—hematologic cancer	0.00711	0.0273	CrCrCtD
Spironolactone—Hydrocortisone—Prednisone—hematologic cancer	0.00684	0.0262	CrCrCtD
Spironolactone—Hydrocortisone—Prednisolone—hematologic cancer	0.00668	0.0256	CrCrCtD
Spironolactone—CYP2C8—Bortezomib—hematologic cancer	0.0066	0.0202	CbGbCtD
Spironolactone—ABCC2—Irinotecan—hematologic cancer	0.00628	0.0192	CbGbCtD
Spironolactone—PGR—ovarian follicle—hematologic cancer	0.00602	0.207	CbGeAlD
Spironolactone—NR3C1—Dexamethasone—hematologic cancer	0.00579	0.0177	CbGbCtD
Spironolactone—ABCC2—Vinblastine—hematologic cancer	0.00558	0.0171	CbGbCtD
Spironolactone—ABCC2—Vincristine—hematologic cancer	0.00549	0.0168	CbGbCtD
Spironolactone—ABCC2—Cisplatin—hematologic cancer	0.00512	0.0157	CbGbCtD
Spironolactone—CYP2C8—Ifosfamide—hematologic cancer	0.00507	0.0155	CbGbCtD
Spironolactone—ABCC2—Etoposide—hematologic cancer	0.00503	0.0154	CbGbCtD
Spironolactone—SLCO1A2—Dexamethasone—hematologic cancer	0.00499	0.0153	CbGbCtD
Spironolactone—CYP2C8—Nilotinib—hematologic cancer	0.0044	0.0135	CbGbCtD
Spironolactone—ABCB1—Daunorubicin—hematologic cancer	0.00428	0.0131	CbGbCtD
Spironolactone—ABCB1—Alitretinoin—hematologic cancer	0.00419	0.0128	CbGbCtD
Spironolactone—ABCC2—Dexamethasone—hematologic cancer	0.00413	0.0127	CbGbCtD
Spironolactone—SLCO1A2—Methotrexate—hematologic cancer	0.00401	0.0123	CbGbCtD
Spironolactone—ABCC2—Doxorubicin—hematologic cancer	0.00343	0.0105	CbGbCtD
Spironolactone—ABCC2—Methotrexate—hematologic cancer	0.00332	0.0102	CbGbCtD
Spironolactone—ABCB1—Imatinib—hematologic cancer	0.00328	0.01	CbGbCtD
Spironolactone—ABCB1—Nilotinib—hematologic cancer	0.00298	0.00913	CbGbCtD
Spironolactone—ABCB1—Vinorelbine—hematologic cancer	0.00295	0.00905	CbGbCtD
Spironolactone—ABCB1—Dasatinib—hematologic cancer	0.00263	0.00807	CbGbCtD
Spironolactone—ABCB1—Mitoxantrone—hematologic cancer	0.0026	0.00797	CbGbCtD
Spironolactone—CYP2C8—Etoposide—hematologic cancer	0.00242	0.00742	CbGbCtD
Spironolactone—ABCB1—Betamethasone—hematologic cancer	0.00232	0.0071	CbGbCtD
Spironolactone—ABCB1—Gemcitabine—hematologic cancer	0.0023	0.00704	CbGbCtD
Spironolactone—ABCB1—Prednisolone—hematologic cancer	0.00229	0.00701	CbGbCtD
Spironolactone—ABCB1—Prednisone—hematologic cancer	0.00216	0.00662	CbGbCtD
Spironolactone—ABCB1—Irinotecan—hematologic cancer	0.00205	0.00627	CbGbCtD
Spironolactone—CYP2C8—Dexamethasone—hematologic cancer	0.00199	0.0061	CbGbCtD
Spironolactone—ABCB1—Vinblastine—hematologic cancer	0.00182	0.00558	CbGbCtD
Spironolactone—ABCB1—Vincristine—hematologic cancer	0.00179	0.00548	CbGbCtD
Spironolactone—CYP11B2—hematopoietic system—hematologic cancer	0.00177	0.061	CbGeAlD
Spironolactone—CYP11B1—hematopoietic system—hematologic cancer	0.00177	0.061	CbGeAlD
Spironolactone—ABCB1—Cisplatin—hematologic cancer	0.00167	0.00511	CbGbCtD
Spironolactone—ABCB1—Etoposide—hematologic cancer	0.00164	0.00502	CbGbCtD
Spironolactone—ABCB1—Dexamethasone—hematologic cancer	0.00135	0.00413	CbGbCtD
Spironolactone—CYP11B1—blood—hematologic cancer	0.00117	0.0404	CbGeAlD
Spironolactone—CYP11B2—blood—hematologic cancer	0.00117	0.0404	CbGeAlD
Spironolactone—ABCB1—Doxorubicin—hematologic cancer	0.00112	0.00343	CbGbCtD
Spironolactone—ABCB1—Methotrexate—hematologic cancer	0.00108	0.00332	CbGbCtD
Spironolactone—SHBG—hematopoietic system—hematologic cancer	0.000807	0.0278	CbGeAlD
Spironolactone—NR3C2—hematopoietic system—hematologic cancer	0.000782	0.0269	CbGeAlD
Spironolactone—PGR—hematopoietic system—hematologic cancer	0.000727	0.025	CbGeAlD
Spironolactone—CYP11B2—lymph node—hematologic cancer	0.000704	0.0242	CbGeAlD
Spironolactone—SLCO1A2—hematopoietic system—hematologic cancer	0.000671	0.0231	CbGeAlD
Spironolactone—SHBG—gonad—hematologic cancer	0.000614	0.0211	CbGeAlD
Spironolactone—AR—hematopoietic system—hematologic cancer	0.000579	0.0199	CbGeAlD
Spironolactone—SHBG—blood—hematologic cancer	0.000535	0.0184	CbGeAlD
Spironolactone—NR3C2—blood—hematologic cancer	0.000518	0.0178	CbGeAlD
Spironolactone—SHBG—bone marrow—hematologic cancer	0.000518	0.0178	CbGeAlD
Spironolactone—PGR—blood—hematologic cancer	0.000482	0.0166	CbGeAlD
Spironolactone—CYP2C8—hematopoietic system—hematologic cancer	0.000469	0.0161	CbGeAlD
Spironolactone—NR3C2—lung—hematologic cancer	0.000454	0.0156	CbGeAlD
Spironolactone—SHBG—testis—hematologic cancer	0.000442	0.0152	CbGeAlD
Spironolactone—AR—gonad—hematologic cancer	0.000441	0.0152	CbGeAlD
Spironolactone—NR3C2—testis—hematologic cancer	0.000429	0.0148	CbGeAlD
Spironolactone—PGR—lung—hematologic cancer	0.000422	0.0145	CbGeAlD
Spironolactone—NR3C1—hematopoietic system—hematologic cancer	0.00042	0.0144	CbGeAlD
Spironolactone—ABCC2—blood—hematologic cancer	0.000414	0.0142	CbGeAlD
Spironolactone—PGR—testis—hematologic cancer	0.000399	0.0137	CbGeAlD
Spironolactone—SLCO1A2—lung—hematologic cancer	0.000389	0.0134	CbGeAlD
Spironolactone—AR—blood—hematologic cancer	0.000384	0.0132	CbGeAlD
Spironolactone—SLCO1A2—testis—hematologic cancer	0.000367	0.0126	CbGeAlD
Spironolactone—ABCC2—testis—hematologic cancer	0.000342	0.0118	CbGeAlD
Spironolactone—AR—lung—hematologic cancer	0.000337	0.0116	CbGeAlD
Spironolactone—NR3C1—gonad—hematologic cancer	0.000319	0.011	CbGeAlD
Spironolactone—AR—testis—hematologic cancer	0.000318	0.0109	CbGeAlD
Spironolactone—NR3C2—lymph node—hematologic cancer	0.000311	0.0107	CbGeAlD
Spironolactone—CYP2C8—blood—hematologic cancer	0.00031	0.0107	CbGeAlD
Spironolactone—PGR—lymph node—hematologic cancer	0.000289	0.00994	CbGeAlD
Spironolactone—NR3C1—blood—hematologic cancer	0.000278	0.00957	CbGeAlD
Spironolactone—Oxandrolone—AR—hematologic cancer	0.000273	0.118	CrCbGaD
Spironolactone—NR3C1—bone marrow—hematologic cancer	0.000269	0.00926	CbGeAlD
Spironolactone—CYP2C8—testis—hematologic cancer	0.000257	0.00883	CbGeAlD
Spironolactone—ABCC2—lymph node—hematologic cancer	0.000248	0.00854	CbGeAlD
Spironolactone—NR3C1—lung—hematologic cancer	0.000244	0.00839	CbGeAlD
Spironolactone—AR—lymph node—hematologic cancer	0.00023	0.00792	CbGeAlD
Spironolactone—NR3C1—testis—hematologic cancer	0.00023	0.00791	CbGeAlD
Spironolactone—ABCB1—hematopoietic system—hematologic cancer	0.000225	0.00773	CbGeAlD
Spironolactone—ABCB1—gonad—hematologic cancer	0.000171	0.00588	CbGeAlD
Spironolactone—NR3C1—lymph node—hematologic cancer	0.000167	0.00574	CbGeAlD
Spironolactone—Testosterone Propionate—UGT1A1—hematologic cancer	0.000155	0.0672	CrCbGaD
Spironolactone—ABCB1—blood—hematologic cancer	0.000149	0.00512	CbGeAlD
Spironolactone—ABCB1—bone marrow—hematologic cancer	0.000144	0.00496	CbGeAlD
Spironolactone—Drospirenone—AR—hematologic cancer	0.000132	0.0572	CrCbGaD
Spironolactone—ABCB1—lung—hematologic cancer	0.00013	0.00449	CbGeAlD
Spironolactone—Fludrocortisone—AR—hematologic cancer	0.000124	0.0539	CrCbGaD
Spironolactone—ABCB1—testis—hematologic cancer	0.000123	0.00424	CbGeAlD
Spironolactone—Testosterone Propionate—AR—hematologic cancer	0.000111	0.048	CrCbGaD
Spironolactone—Hydrocortamate—NR3C1—hematologic cancer	0.000108	0.0468	CrCbGaD
Spironolactone—Cortisone acetate—NR3C1—hematologic cancer	0.000106	0.0461	CrCbGaD
Spironolactone—Fluoxymesterone—AR—hematologic cancer	0.000103	0.0445	CrCbGaD
Spironolactone—Megestrol acetate—NR3C1—hematologic cancer	0.000102	0.0444	CrCbGaD
Spironolactone—ABCB1—lymph node—hematologic cancer	8.92e-05	0.00307	CbGeAlD
Spironolactone—Medroxyprogesterone Acetate—AR—hematologic cancer	8.8e-05	0.0382	CrCbGaD
Spironolactone—Fludrocortisone—NR3C1—hematologic cancer	8.42e-05	0.0365	CrCbGaD
Spironolactone—Methyltestosterone—AR—hematologic cancer	8.28e-05	0.0359	CrCbGaD
Spironolactone—Fluoxymesterone—ESR1—hematologic cancer	7.9e-05	0.0343	CrCbGaD
Spironolactone—Fluoxymesterone—NR3C1—hematologic cancer	6.95e-05	0.0302	CrCbGaD
Spironolactone—Medroxyprogesterone Acetate—ESR1—hematologic cancer	6.78e-05	0.0294	CrCbGaD
Spironolactone—Medroxyprogesterone Acetate—NR3C1—hematologic cancer	5.97e-05	0.0259	CrCbGaD
Spironolactone—Progesterone—SLC22A1—hematologic cancer	5.72e-05	0.0248	CrCbGaD
Spironolactone—Testosterone—SLC22A1—hematologic cancer	5.41e-05	0.0235	CrCbGaD
Spironolactone—Progesterone—AR—hematologic cancer	5.08e-05	0.0221	CrCbGaD
Spironolactone—Megestrol acetate—ABCB1—hematologic cancer	4.94e-05	0.0214	CrCbGaD
Spironolactone—Hydrocortisone—ABCG2—hematologic cancer	4.9e-05	0.0213	CrCbGaD
Spironolactone—Testosterone—AR—hematologic cancer	4.8e-05	0.0208	CrCbGaD
Spironolactone—Hydrocortisone—NR3C1—hematologic cancer	4.23e-05	0.0184	CrCbGaD
Spironolactone—Gastritis—Doxorubicin—hematologic cancer	3.95e-05	0.000418	CcSEcCtD
Spironolactone—Dermatitis—Bleomycin—hematologic cancer	3.94e-05	0.000418	CcSEcCtD
Spironolactone—Hypersensitivity—Ifosfamide—hematologic cancer	3.94e-05	0.000418	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Methotrexate—hematologic cancer	3.93e-05	0.000417	CcSEcCtD
Spironolactone—Vomiting—Vinorelbine—hematologic cancer	3.92e-05	0.000415	CcSEcCtD
Spironolactone—Progesterone—ESR1—hematologic cancer	3.91e-05	0.017	CrCbGaD
Spironolactone—Body temperature increased—Gemcitabine—hematologic cancer	3.91e-05	0.000415	CcSEcCtD
Spironolactone—Renal failure—Methotrexate—hematologic cancer	3.9e-05	0.000414	CcSEcCtD
Spironolactone—Diarrhoea—Thalidomide—hematologic cancer	3.89e-05	0.000413	CcSEcCtD
Spironolactone—Dizziness—Thiotepa—hematologic cancer	3.89e-05	0.000412	CcSEcCtD
Spironolactone—Rash—Vinorelbine—hematologic cancer	3.88e-05	0.000412	CcSEcCtD
Spironolactone—Dermatitis—Vinorelbine—hematologic cancer	3.88e-05	0.000411	CcSEcCtD
Spironolactone—Headache—Vinorelbine—hematologic cancer	3.86e-05	0.000409	CcSEcCtD
Spironolactone—Hypersensitivity—Vincristine—hematologic cancer	3.84e-05	0.000408	CcSEcCtD
Spironolactone—Malaise—Dexamethasone—hematologic cancer	3.84e-05	0.000407	CcSEcCtD
Spironolactone—Malaise—Betamethasone—hematologic cancer	3.84e-05	0.000407	CcSEcCtD
Spironolactone—Anaphylactic shock—Triamcinolone—hematologic cancer	3.83e-05	0.000406	CcSEcCtD
Spironolactone—Pruritus—Alitretinoin—hematologic cancer	3.83e-05	0.000406	CcSEcCtD
Spironolactone—Eosinophilia—Doxorubicin—hematologic cancer	3.82e-05	0.000405	CcSEcCtD
Spironolactone—Feeling abnormal—Cisplatin—hematologic cancer	3.8e-05	0.000403	CcSEcCtD
Spironolactone—Pruritus—Ifosfamide—hematologic cancer	3.78e-05	0.000401	CcSEcCtD
Spironolactone—Testosterone—ABCG2—hematologic cancer	3.78e-05	0.0164	CrCbGaD
Spironolactone—Alopecia—Prednisone—hematologic cancer	3.77e-05	0.000399	CcSEcCtD
Spironolactone—Dizziness—Thalidomide—hematologic cancer	3.76e-05	0.000399	CcSEcCtD
Spironolactone—Somnolence—Etoposide—hematologic cancer	3.76e-05	0.000398	CcSEcCtD
Spironolactone—Nausea—Bortezomib—hematologic cancer	3.75e-05	0.000397	CcSEcCtD
Spironolactone—Hypersensitivity—Mitoxantrone—hematologic cancer	3.74e-05	0.000397	CcSEcCtD
Spironolactone—Hypersensitivity—Irinotecan—hematologic cancer	3.74e-05	0.000397	CcSEcCtD
Spironolactone—Vomiting—Thiotepa—hematologic cancer	3.74e-05	0.000397	CcSEcCtD
Spironolactone—Diarrhoea—Carmustine—hematologic cancer	3.74e-05	0.000396	CcSEcCtD
Spironolactone—Nausea—Bleomycin—hematologic cancer	3.72e-05	0.000394	CcSEcCtD
Spironolactone—Drowsiness—Epirubicin—hematologic cancer	3.71e-05	0.000394	CcSEcCtD
Spironolactone—Rash—Thiotepa—hematologic cancer	3.71e-05	0.000393	CcSEcCtD
Spironolactone—Dermatitis—Thiotepa—hematologic cancer	3.7e-05	0.000393	CcSEcCtD
Spironolactone—Diarrhoea—Alitretinoin—hematologic cancer	3.7e-05	0.000393	CcSEcCtD
Spironolactone—Agranulocytosis—Methotrexate—hematologic cancer	3.7e-05	0.000393	CcSEcCtD
Spironolactone—Headache—Thiotepa—hematologic cancer	3.68e-05	0.000391	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Epirubicin—hematologic cancer	3.68e-05	0.00039	CcSEcCtD
Spironolactone—Diarrhoea—Ifosfamide—hematologic cancer	3.66e-05	0.000388	CcSEcCtD
Spironolactone—Nausea—Vinorelbine—hematologic cancer	3.66e-05	0.000388	CcSEcCtD
Spironolactone—Renal failure—Epirubicin—hematologic cancer	3.65e-05	0.000387	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Etoposide—hematologic cancer	3.65e-05	0.000387	CcSEcCtD
Spironolactone—Body temperature increased—Cisplatin—hematologic cancer	3.65e-05	0.000387	CcSEcCtD
Spironolactone—Vomiting—Thalidomide—hematologic cancer	3.62e-05	0.000384	CcSEcCtD
Spironolactone—Dizziness—Carmustine—hematologic cancer	3.61e-05	0.000383	CcSEcCtD
Spironolactone—Rash—Thalidomide—hematologic cancer	3.59e-05	0.00038	CcSEcCtD
Spironolactone—Discomfort—Dexamethasone—hematologic cancer	3.58e-05	0.00038	CcSEcCtD
Spironolactone—Discomfort—Betamethasone—hematologic cancer	3.58e-05	0.00038	CcSEcCtD
Spironolactone—Dermatitis—Thalidomide—hematologic cancer	3.58e-05	0.00038	CcSEcCtD
Spironolactone—Dizziness—Alitretinoin—hematologic cancer	3.58e-05	0.00038	CcSEcCtD
Spironolactone—Diarrhoea—Vincristine—hematologic cancer	3.57e-05	0.000378	CcSEcCtD
Spironolactone—Headache—Thalidomide—hematologic cancer	3.56e-05	0.000378	CcSEcCtD
Spironolactone—Dizziness—Ifosfamide—hematologic cancer	3.54e-05	0.000375	CcSEcCtD
Spironolactone—Pruritus—Gemcitabine—hematologic cancer	3.5e-05	0.000371	CcSEcCtD
Spironolactone—Nausea—Thiotepa—hematologic cancer	3.49e-05	0.000371	CcSEcCtD
Spironolactone—Feeling abnormal—Etoposide—hematologic cancer	3.48e-05	0.000369	CcSEcCtD
Spironolactone—Anaphylactic shock—Dexamethasone—hematologic cancer	3.48e-05	0.000369	CcSEcCtD
Spironolactone—Anaphylactic shock—Betamethasone—hematologic cancer	3.48e-05	0.000369	CcSEcCtD
Spironolactone—Diarrhoea—Mitoxantrone—hematologic cancer	3.48e-05	0.000369	CcSEcCtD
Spironolactone—Diarrhoea—Irinotecan—hematologic cancer	3.48e-05	0.000369	CcSEcCtD
Spironolactone—Vomiting—Carmustine—hematologic cancer	3.47e-05	0.000368	CcSEcCtD
Spironolactone—Agranulocytosis—Epirubicin—hematologic cancer	3.47e-05	0.000368	CcSEcCtD
Spironolactone—Dizziness—Vincristine—hematologic cancer	3.45e-05	0.000366	CcSEcCtD
Spironolactone—Progesterone—NR3C1—hematologic cancer	3.45e-05	0.015	CrCbGaD
Spironolactone—Rash—Carmustine—hematologic cancer	3.44e-05	0.000365	CcSEcCtD
Spironolactone—Ill-defined disorder—Prednisone—hematologic cancer	3.44e-05	0.000365	CcSEcCtD
Spironolactone—Dermatitis—Carmustine—hematologic cancer	3.44e-05	0.000365	CcSEcCtD
Spironolactone—Vomiting—Alitretinoin—hematologic cancer	3.44e-05	0.000365	CcSEcCtD
Spironolactone—Drowsiness—Doxorubicin—hematologic cancer	3.44e-05	0.000364	CcSEcCtD
Spironolactone—Feeling abnormal—Prednisolone—hematologic cancer	3.43e-05	0.000364	CcSEcCtD
Spironolactone—Headache—Carmustine—hematologic cancer	3.42e-05	0.000363	CcSEcCtD
Spironolactone—Rash—Alitretinoin—hematologic cancer	3.41e-05	0.000362	CcSEcCtD
Spironolactone—Dermatitis—Alitretinoin—hematologic cancer	3.41e-05	0.000362	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Doxorubicin—hematologic cancer	3.41e-05	0.000361	CcSEcCtD
Spironolactone—Thrombocytopenia—Betamethasone—hematologic cancer	3.4e-05	0.000361	CcSEcCtD
Spironolactone—Thrombocytopenia—Dexamethasone—hematologic cancer	3.4e-05	0.000361	CcSEcCtD
Spironolactone—Vomiting—Ifosfamide—hematologic cancer	3.4e-05	0.000361	CcSEcCtD
Spironolactone—Hypersensitivity—Cisplatin—hematologic cancer	3.4e-05	0.00036	CcSEcCtD
Spironolactone—Headache—Alitretinoin—hematologic cancer	3.39e-05	0.00036	CcSEcCtD
Spironolactone—Diarrhoea—Gemcitabine—hematologic cancer	3.39e-05	0.000359	CcSEcCtD
Spironolactone—Nausea—Thalidomide—hematologic cancer	3.38e-05	0.000358	CcSEcCtD
Spironolactone—Renal failure—Doxorubicin—hematologic cancer	3.38e-05	0.000358	CcSEcCtD
Spironolactone—Rash—Ifosfamide—hematologic cancer	3.37e-05	0.000358	CcSEcCtD
Spironolactone—Dermatitis—Ifosfamide—hematologic cancer	3.37e-05	0.000357	CcSEcCtD
Spironolactone—Erythema multiforme—Methotrexate—hematologic cancer	3.37e-05	0.000357	CcSEcCtD
Spironolactone—Dizziness—Irinotecan—hematologic cancer	3.36e-05	0.000356	CcSEcCtD
Spironolactone—Urticaria—Etoposide—hematologic cancer	3.36e-05	0.000356	CcSEcCtD
Spironolactone—Malaise—Prednisone—hematologic cancer	3.35e-05	0.000355	CcSEcCtD
Spironolactone—Body temperature increased—Etoposide—hematologic cancer	3.34e-05	0.000354	CcSEcCtD
Spironolactone—Vomiting—Vincristine—hematologic cancer	3.32e-05	0.000352	CcSEcCtD
Spironolactone—Urticaria—Prednisolone—hematologic cancer	3.31e-05	0.000351	CcSEcCtD
Spironolactone—Rash—Vincristine—hematologic cancer	3.29e-05	0.000349	CcSEcCtD
Spironolactone—Dermatitis—Vincristine—hematologic cancer	3.29e-05	0.000348	CcSEcCtD
Spironolactone—Headache—Vincristine—hematologic cancer	3.27e-05	0.000347	CcSEcCtD
Spironolactone—Nausea—Carmustine—hematologic cancer	3.25e-05	0.000344	CcSEcCtD
Spironolactone—Vomiting—Irinotecan—hematologic cancer	3.23e-05	0.000343	CcSEcCtD
Spironolactone—Vomiting—Mitoxantrone—hematologic cancer	3.23e-05	0.000343	CcSEcCtD
Spironolactone—Nausea—Alitretinoin—hematologic cancer	3.21e-05	0.000341	CcSEcCtD
Spironolactone—Agranulocytosis—Doxorubicin—hematologic cancer	3.21e-05	0.00034	CcSEcCtD
Spironolactone—Rash—Mitoxantrone—hematologic cancer	3.2e-05	0.00034	CcSEcCtD
Spironolactone—Rash—Irinotecan—hematologic cancer	3.2e-05	0.00034	CcSEcCtD
Spironolactone—Dermatitis—Mitoxantrone—hematologic cancer	3.2e-05	0.000339	CcSEcCtD
Spironolactone—Dermatitis—Irinotecan—hematologic cancer	3.2e-05	0.000339	CcSEcCtD
Spironolactone—Headache—Mitoxantrone—hematologic cancer	3.18e-05	0.000337	CcSEcCtD
Spironolactone—Headache—Irinotecan—hematologic cancer	3.18e-05	0.000337	CcSEcCtD
Spironolactone—Nausea—Ifosfamide—hematologic cancer	3.18e-05	0.000337	CcSEcCtD
Spironolactone—Feeling abnormal—Triamcinolone—hematologic cancer	3.16e-05	0.000335	CcSEcCtD
Spironolactone—Diarrhoea—Cisplatin—hematologic cancer	3.16e-05	0.000335	CcSEcCtD
Spironolactone—Erythema multiforme—Epirubicin—hematologic cancer	3.15e-05	0.000334	CcSEcCtD
Spironolactone—Alopecia—Methotrexate—hematologic cancer	3.15e-05	0.000334	CcSEcCtD
Spironolactone—Vomiting—Gemcitabine—hematologic cancer	3.15e-05	0.000334	CcSEcCtD
Spironolactone—Discomfort—Prednisone—hematologic cancer	3.12e-05	0.000331	CcSEcCtD
Spironolactone—Rash—Gemcitabine—hematologic cancer	3.12e-05	0.000331	CcSEcCtD
Spironolactone—Dermatitis—Gemcitabine—hematologic cancer	3.12e-05	0.000331	CcSEcCtD
Spironolactone—Hypersensitivity—Etoposide—hematologic cancer	3.11e-05	0.00033	CcSEcCtD
Spironolactone—Headache—Gemcitabine—hematologic cancer	3.1e-05	0.000329	CcSEcCtD
Spironolactone—Nausea—Vincristine—hematologic cancer	3.1e-05	0.000329	CcSEcCtD
Spironolactone—Hypersensitivity—Prednisolone—hematologic cancer	3.07e-05	0.000326	CcSEcCtD
Spironolactone—Urticaria—Triamcinolone—hematologic cancer	3.04e-05	0.000323	CcSEcCtD
Spironolactone—Body temperature increased—Triamcinolone—hematologic cancer	3.03e-05	0.000321	CcSEcCtD
Spironolactone—Anaphylactic shock—Prednisone—hematologic cancer	3.03e-05	0.000321	CcSEcCtD
Spironolactone—Nausea—Mitoxantrone—hematologic cancer	3.02e-05	0.00032	CcSEcCtD
Spironolactone—Nausea—Irinotecan—hematologic cancer	3.02e-05	0.00032	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Betamethasone—hematologic cancer	3e-05	0.000318	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Dexamethasone—hematologic cancer	3e-05	0.000318	CcSEcCtD
Spironolactone—Pruritus—Etoposide—hematologic cancer	2.99e-05	0.000317	CcSEcCtD
Spironolactone—Alopecia—Epirubicin—hematologic cancer	2.95e-05	0.000312	CcSEcCtD
Spironolactone—Nausea—Gemcitabine—hematologic cancer	2.94e-05	0.000312	CcSEcCtD
Spironolactone—Vomiting—Cisplatin—hematologic cancer	2.93e-05	0.000311	CcSEcCtD
Spironolactone—Erythema multiforme—Doxorubicin—hematologic cancer	2.92e-05	0.000309	CcSEcCtD
Spironolactone—Rash—Cisplatin—hematologic cancer	2.91e-05	0.000308	CcSEcCtD
Spironolactone—Dermatitis—Cisplatin—hematologic cancer	2.91e-05	0.000308	CcSEcCtD
Spironolactone—Diarrhoea—Etoposide—hematologic cancer	2.89e-05	0.000307	CcSEcCtD
Spironolactone—Ill-defined disorder—Methotrexate—hematologic cancer	2.88e-05	0.000305	CcSEcCtD
Spironolactone—Feeling abnormal—Betamethasone—hematologic cancer	2.87e-05	0.000304	CcSEcCtD
Spironolactone—Feeling abnormal—Dexamethasone—hematologic cancer	2.87e-05	0.000304	CcSEcCtD
Spironolactone—Methyltestosterone—ALB—hematologic cancer	2.84e-05	0.0123	CrCbGaD
Spironolactone—Hypersensitivity—Triamcinolone—hematologic cancer	2.82e-05	0.000299	CcSEcCtD
Spironolactone—Malaise—Methotrexate—hematologic cancer	2.8e-05	0.000297	CcSEcCtD
Spironolactone—Dizziness—Etoposide—hematologic cancer	2.79e-05	0.000296	CcSEcCtD
Spironolactone—Muscle spasms—Epirubicin—hematologic cancer	2.79e-05	0.000296	CcSEcCtD
Spironolactone—Leukopenia—Methotrexate—hematologic cancer	2.78e-05	0.000294	CcSEcCtD
Spironolactone—Urticaria—Betamethasone—hematologic cancer	2.76e-05	0.000293	CcSEcCtD
Spironolactone—Urticaria—Dexamethasone—hematologic cancer	2.76e-05	0.000293	CcSEcCtD
Spironolactone—Dizziness—Prednisolone—hematologic cancer	2.76e-05	0.000292	CcSEcCtD
Spironolactone—Body temperature increased—Dexamethasone—hematologic cancer	2.75e-05	0.000292	CcSEcCtD
Spironolactone—Body temperature increased—Betamethasone—hematologic cancer	2.75e-05	0.000292	CcSEcCtD
Spironolactone—Nausea—Cisplatin—hematologic cancer	2.74e-05	0.000291	CcSEcCtD
Spironolactone—Alopecia—Doxorubicin—hematologic cancer	2.73e-05	0.000289	CcSEcCtD
Spironolactone—Pruritus—Triamcinolone—hematologic cancer	2.71e-05	0.000288	CcSEcCtD
Spironolactone—Ill-defined disorder—Epirubicin—hematologic cancer	2.69e-05	0.000286	CcSEcCtD
Spironolactone—Vomiting—Etoposide—hematologic cancer	2.69e-05	0.000285	CcSEcCtD
Spironolactone—Rash—Etoposide—hematologic cancer	2.66e-05	0.000283	CcSEcCtD
Spironolactone—Dermatitis—Etoposide—hematologic cancer	2.66e-05	0.000282	CcSEcCtD
Spironolactone—Headache—Etoposide—hematologic cancer	2.65e-05	0.000281	CcSEcCtD
Spironolactone—Rash—Prednisolone—hematologic cancer	2.63e-05	0.000279	CcSEcCtD
Spironolactone—Dermatitis—Prednisolone—hematologic cancer	2.62e-05	0.000278	CcSEcCtD
Spironolactone—Malaise—Epirubicin—hematologic cancer	2.62e-05	0.000278	CcSEcCtD
Spironolactone—Headache—Prednisolone—hematologic cancer	2.61e-05	0.000277	CcSEcCtD
Spironolactone—Discomfort—Methotrexate—hematologic cancer	2.61e-05	0.000277	CcSEcCtD
Spironolactone—Leukopenia—Epirubicin—hematologic cancer	2.6e-05	0.000275	CcSEcCtD
Spironolactone—Muscle spasms—Doxorubicin—hematologic cancer	2.58e-05	0.000274	CcSEcCtD
Spironolactone—Confusional state—Methotrexate—hematologic cancer	2.55e-05	0.000271	CcSEcCtD
Spironolactone—Dizziness—Triamcinolone—hematologic cancer	2.53e-05	0.000269	CcSEcCtD
Spironolactone—Anaphylactic shock—Methotrexate—hematologic cancer	2.53e-05	0.000268	CcSEcCtD
Spironolactone—Nausea—Etoposide—hematologic cancer	2.51e-05	0.000266	CcSEcCtD
Spironolactone—Feeling abnormal—Prednisone—hematologic cancer	2.5e-05	0.000265	CcSEcCtD
Spironolactone—Ill-defined disorder—Doxorubicin—hematologic cancer	2.49e-05	0.000264	CcSEcCtD
Spironolactone—Thrombocytopenia—Methotrexate—hematologic cancer	2.48e-05	0.000263	CcSEcCtD
Spironolactone—Nausea—Prednisolone—hematologic cancer	2.48e-05	0.000263	CcSEcCtD
Spironolactone—Pruritus—Dexamethasone—hematologic cancer	2.46e-05	0.000261	CcSEcCtD
Spironolactone—Pruritus—Betamethasone—hematologic cancer	2.46e-05	0.000261	CcSEcCtD
Spironolactone—Discomfort—Epirubicin—hematologic cancer	2.44e-05	0.000259	CcSEcCtD
Spironolactone—Vomiting—Triamcinolone—hematologic cancer	2.44e-05	0.000258	CcSEcCtD
Spironolactone—Malaise—Doxorubicin—hematologic cancer	2.42e-05	0.000257	CcSEcCtD
Spironolactone—Rash—Triamcinolone—hematologic cancer	2.42e-05	0.000256	CcSEcCtD
Spironolactone—Dermatitis—Triamcinolone—hematologic cancer	2.41e-05	0.000256	CcSEcCtD
Spironolactone—Urticaria—Prednisone—hematologic cancer	2.41e-05	0.000255	CcSEcCtD
Spironolactone—Leukopenia—Doxorubicin—hematologic cancer	2.4e-05	0.000255	CcSEcCtD
Spironolactone—Headache—Triamcinolone—hematologic cancer	2.4e-05	0.000255	CcSEcCtD
Spironolactone—Body temperature increased—Prednisone—hematologic cancer	2.39e-05	0.000254	CcSEcCtD
Spironolactone—Confusional state—Epirubicin—hematologic cancer	2.39e-05	0.000253	CcSEcCtD
Spironolactone—Diarrhoea—Betamethasone—hematologic cancer	2.38e-05	0.000252	CcSEcCtD
Spironolactone—Diarrhoea—Dexamethasone—hematologic cancer	2.38e-05	0.000252	CcSEcCtD
Spironolactone—Anaphylactic shock—Epirubicin—hematologic cancer	2.37e-05	0.000251	CcSEcCtD
Spironolactone—Thrombocytopenia—Epirubicin—hematologic cancer	2.32e-05	0.000246	CcSEcCtD
Spironolactone—Dizziness—Dexamethasone—hematologic cancer	2.3e-05	0.000244	CcSEcCtD
Spironolactone—Dizziness—Betamethasone—hematologic cancer	2.3e-05	0.000244	CcSEcCtD
Spironolactone—Nausea—Triamcinolone—hematologic cancer	2.28e-05	0.000241	CcSEcCtD
Spironolactone—Discomfort—Doxorubicin—hematologic cancer	2.26e-05	0.00024	CcSEcCtD
Spironolactone—Somnolence—Methotrexate—hematologic cancer	2.25e-05	0.000239	CcSEcCtD
Spironolactone—Hypersensitivity—Prednisone—hematologic cancer	2.23e-05	0.000237	CcSEcCtD
Spironolactone—Vomiting—Dexamethasone—hematologic cancer	2.21e-05	0.000234	CcSEcCtD
Spironolactone—Vomiting—Betamethasone—hematologic cancer	2.21e-05	0.000234	CcSEcCtD
Spironolactone—Confusional state—Doxorubicin—hematologic cancer	2.21e-05	0.000234	CcSEcCtD
Spironolactone—Rash—Dexamethasone—hematologic cancer	2.19e-05	0.000233	CcSEcCtD
Spironolactone—Rash—Betamethasone—hematologic cancer	2.19e-05	0.000233	CcSEcCtD
Spironolactone—Anaphylactic shock—Doxorubicin—hematologic cancer	2.19e-05	0.000232	CcSEcCtD
Spironolactone—Dermatitis—Dexamethasone—hematologic cancer	2.19e-05	0.000232	CcSEcCtD
Spironolactone—Dermatitis—Betamethasone—hematologic cancer	2.19e-05	0.000232	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.18e-05	0.000232	CcSEcCtD
Spironolactone—Headache—Dexamethasone—hematologic cancer	2.18e-05	0.000231	CcSEcCtD
Spironolactone—Headache—Betamethasone—hematologic cancer	2.18e-05	0.000231	CcSEcCtD
Spironolactone—Thrombocytopenia—Doxorubicin—hematologic cancer	2.15e-05	0.000228	CcSEcCtD
Spironolactone—Pruritus—Prednisone—hematologic cancer	2.14e-05	0.000227	CcSEcCtD
Spironolactone—Somnolence—Epirubicin—hematologic cancer	2.11e-05	0.000223	CcSEcCtD
Spironolactone—Feeling abnormal—Methotrexate—hematologic cancer	2.09e-05	0.000221	CcSEcCtD
Spironolactone—Diarrhoea—Prednisone—hematologic cancer	2.07e-05	0.00022	CcSEcCtD
Spironolactone—Nausea—Dexamethasone—hematologic cancer	2.07e-05	0.000219	CcSEcCtD
Spironolactone—Nausea—Betamethasone—hematologic cancer	2.07e-05	0.000219	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.04e-05	0.000217	CcSEcCtD
Spironolactone—Hydrocortisone—ABCB1—hematologic cancer	2.04e-05	0.00886	CrCbGaD
Spironolactone—Urticaria—Methotrexate—hematologic cancer	2.01e-05	0.000213	CcSEcCtD
Spironolactone—Dizziness—Prednisone—hematologic cancer	2e-05	0.000212	CcSEcCtD
Spironolactone—Body temperature increased—Methotrexate—hematologic cancer	2e-05	0.000212	CcSEcCtD
Spironolactone—Feeling abnormal—Epirubicin—hematologic cancer	1.95e-05	0.000207	CcSEcCtD
Spironolactone—Somnolence—Doxorubicin—hematologic cancer	1.95e-05	0.000207	CcSEcCtD
Spironolactone—Vomiting—Prednisone—hematologic cancer	1.93e-05	0.000204	CcSEcCtD
Spironolactone—Rash—Prednisone—hematologic cancer	1.91e-05	0.000202	CcSEcCtD
Spironolactone—Dermatitis—Prednisone—hematologic cancer	1.91e-05	0.000202	CcSEcCtD
Spironolactone—Headache—Prednisone—hematologic cancer	1.9e-05	0.000201	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.89e-05	0.000201	CcSEcCtD
Spironolactone—Urticaria—Epirubicin—hematologic cancer	1.88e-05	0.0002	CcSEcCtD
Spironolactone—Body temperature increased—Epirubicin—hematologic cancer	1.87e-05	0.000199	CcSEcCtD
Spironolactone—Hypersensitivity—Methotrexate—hematologic cancer	1.86e-05	0.000198	CcSEcCtD
Spironolactone—Feeling abnormal—Doxorubicin—hematologic cancer	1.81e-05	0.000192	CcSEcCtD
Spironolactone—Nausea—Prednisone—hematologic cancer	1.8e-05	0.000191	CcSEcCtD
Spironolactone—Pruritus—Methotrexate—hematologic cancer	1.79e-05	0.00019	CcSEcCtD
Spironolactone—Hypersensitivity—Epirubicin—hematologic cancer	1.74e-05	0.000185	CcSEcCtD
Spironolactone—Urticaria—Doxorubicin—hematologic cancer	1.74e-05	0.000185	CcSEcCtD
Spironolactone—Body temperature increased—Doxorubicin—hematologic cancer	1.73e-05	0.000184	CcSEcCtD
Spironolactone—Diarrhoea—Methotrexate—hematologic cancer	1.73e-05	0.000184	CcSEcCtD
Spironolactone—Pruritus—Epirubicin—hematologic cancer	1.68e-05	0.000178	CcSEcCtD
Spironolactone—Dizziness—Methotrexate—hematologic cancer	1.67e-05	0.000177	CcSEcCtD
Spironolactone—Progesterone—ABCB1—hematologic cancer	1.66e-05	0.00722	CrCbGaD
Spironolactone—Testosterone—ALB—hematologic cancer	1.65e-05	0.00715	CrCbGaD
Spironolactone—Diarrhoea—Epirubicin—hematologic cancer	1.62e-05	0.000172	CcSEcCtD
Spironolactone—Hypersensitivity—Doxorubicin—hematologic cancer	1.61e-05	0.000171	CcSEcCtD
Spironolactone—Vomiting—Methotrexate—hematologic cancer	1.61e-05	0.000171	CcSEcCtD
Spironolactone—Rash—Methotrexate—hematologic cancer	1.6e-05	0.000169	CcSEcCtD
Spironolactone—Dermatitis—Methotrexate—hematologic cancer	1.59e-05	0.000169	CcSEcCtD
Spironolactone—Headache—Methotrexate—hematologic cancer	1.59e-05	0.000168	CcSEcCtD
Spironolactone—Testosterone—ABCB1—hematologic cancer	1.57e-05	0.00682	CrCbGaD
Spironolactone—Dizziness—Epirubicin—hematologic cancer	1.57e-05	0.000166	CcSEcCtD
Spironolactone—Pruritus—Doxorubicin—hematologic cancer	1.55e-05	0.000164	CcSEcCtD
Spironolactone—Vomiting—Epirubicin—hematologic cancer	1.51e-05	0.00016	CcSEcCtD
Spironolactone—Nausea—Methotrexate—hematologic cancer	1.5e-05	0.000159	CcSEcCtD
Spironolactone—Diarrhoea—Doxorubicin—hematologic cancer	1.5e-05	0.000159	CcSEcCtD
Spironolactone—Rash—Epirubicin—hematologic cancer	1.49e-05	0.000158	CcSEcCtD
Spironolactone—Dermatitis—Epirubicin—hematologic cancer	1.49e-05	0.000158	CcSEcCtD
Spironolactone—Headache—Epirubicin—hematologic cancer	1.48e-05	0.000157	CcSEcCtD
Spironolactone—Dizziness—Doxorubicin—hematologic cancer	1.45e-05	0.000154	CcSEcCtD
Spironolactone—Nausea—Epirubicin—hematologic cancer	1.41e-05	0.000149	CcSEcCtD
Spironolactone—Vomiting—Doxorubicin—hematologic cancer	1.39e-05	0.000148	CcSEcCtD
Spironolactone—Rash—Doxorubicin—hematologic cancer	1.38e-05	0.000147	CcSEcCtD
Spironolactone—Dermatitis—Doxorubicin—hematologic cancer	1.38e-05	0.000146	CcSEcCtD
Spironolactone—Headache—Doxorubicin—hematologic cancer	1.37e-05	0.000146	CcSEcCtD
Spironolactone—Nausea—Doxorubicin—hematologic cancer	1.3e-05	0.000138	CcSEcCtD
Spironolactone—PGR—Signaling Pathways—KITLG—hematologic cancer	4.73e-06	8.57e-05	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—ALB—hematologic cancer	4.72e-06	8.56e-05	CbGpPWpGaD
Spironolactone—AR—Gene Expression—NR3C1—hematologic cancer	4.71e-06	8.54e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.68e-06	8.48e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CYCS—hematologic cancer	4.66e-06	8.43e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—AGRN—hematologic cancer	4.65e-06	8.43e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—MTAP—hematologic cancer	4.64e-06	8.4e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	4.63e-06	8.4e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—HSP90AA1—hematologic cancer	4.63e-06	8.38e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—STAT5A—hematologic cancer	4.62e-06	8.38e-05	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—MAPK3—hematologic cancer	4.61e-06	8.35e-05	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—CREBBP—hematologic cancer	4.6e-06	8.34e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CDKN2B—hematologic cancer	4.58e-06	8.3e-05	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PIK3CD—hematologic cancer	4.56e-06	8.25e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	4.54e-06	8.23e-05	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—ALB—hematologic cancer	4.5e-06	8.15e-05	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—MYC—hematologic cancer	4.48e-06	8.12e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PIK3CG—hematologic cancer	4.47e-06	8.09e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CD86—hematologic cancer	4.43e-06	8.03e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	4.42e-06	8.01e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—AR—hematologic cancer	4.42e-06	8.01e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	4.41e-06	7.99e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—IDH2—hematologic cancer	4.41e-06	7.99e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—HMMR—hematologic cancer	4.41e-06	7.99e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HES1—hematologic cancer	4.37e-06	7.92e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NCOR1—hematologic cancer	4.35e-06	7.87e-05	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—MYC—hematologic cancer	4.32e-06	7.83e-05	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PIK3R1—hematologic cancer	4.3e-06	7.79e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CSF2—hematologic cancer	4.3e-06	7.79e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—FGF1—hematologic cancer	4.3e-06	7.79e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	4.28e-06	7.75e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	4.27e-06	7.73e-05	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—CYCS—hematologic cancer	4.25e-06	7.71e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—FOXO1—hematologic cancer	4.24e-06	7.67e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PDGFRB—hematologic cancer	4.23e-06	7.66e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	4.17e-06	7.56e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.16e-06	7.54e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PDGFRA—hematologic cancer	4.16e-06	7.54e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	4.16e-06	7.54e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PRKCG—hematologic cancer	4.15e-06	7.52e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—JAK1—hematologic cancer	4.15e-06	7.52e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ARNTL—hematologic cancer	4.15e-06	7.51e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—CREBBP—hematologic cancer	4.14e-06	7.5e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—FHL2—hematologic cancer	4.13e-06	7.49e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GSTP1—hematologic cancer	4.1e-06	7.43e-05	CbGpPWpGaD
Spironolactone—AR—Gene Expression—MAPK14—hematologic cancer	4.08e-06	7.39e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—CDKN2B—hematologic cancer	4.07e-06	7.38e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	4.07e-06	7.37e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—AGRN—hematologic cancer	4.05e-06	7.35e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CA9—hematologic cancer	4.04e-06	7.31e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ACP5—hematologic cancer	4.04e-06	7.31e-05	CbGpPWpGaD
Spironolactone—AR—Gene Expression—ESR1—hematologic cancer	4e-06	7.25e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NCOR2—hematologic cancer	3.98e-06	7.22e-05	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PIK3CB—hematologic cancer	3.97e-06	7.19e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.97e-06	7.19e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	3.96e-06	7.17e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PIK3CD—hematologic cancer	3.93e-06	7.11e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ABCB1—hematologic cancer	3.88e-06	7.04e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—ALB—hematologic cancer	3.88e-06	7.02e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IL2RA—hematologic cancer	3.87e-06	7.02e-05	CbGpPWpGaD
Spironolactone—AR—Gene Expression—NOTCH1—hematologic cancer	3.87e-06	7.01e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—NCOR1—hematologic cancer	3.86e-06	7e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	3.85e-06	6.98e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—IDH2—hematologic cancer	3.84e-06	6.96e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—HMMR—hematologic cancer	3.84e-06	6.96e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TERT—hematologic cancer	3.83e-06	6.94e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—IDH1—hematologic cancer	3.79e-06	6.87e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GSTM1—hematologic cancer	3.77e-06	6.83e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—NCOR1—hematologic cancer	3.77e-06	6.83e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ABCC3—hematologic cancer	3.75e-06	6.8e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—TXN—hematologic cancer	3.75e-06	6.8e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GSTO1—hematologic cancer	3.75e-06	6.8e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PDGFB—hematologic cancer	3.74e-06	6.77e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PIK3R1—hematologic cancer	3.71e-06	6.72e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SPHK1—hematologic cancer	3.67e-06	6.65e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TSC2—hematologic cancer	3.65e-06	6.62e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	3.65e-06	6.61e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ARNTL—hematologic cancer	3.61e-06	6.55e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	3.55e-06	6.42e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	3.54e-06	6.41e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—UGT1A1—hematologic cancer	3.53e-06	6.39e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CA9—hematologic cancer	3.52e-06	6.37e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ACP5—hematologic cancer	3.52e-06	6.37e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—FGFR3—hematologic cancer	3.52e-06	6.37e-05	CbGpPWpGaD
Spironolactone—AR—Gene Expression—CREBBP—hematologic cancer	3.51e-06	6.35e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MAPK14—hematologic cancer	3.48e-06	6.31e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NCOR2—hematologic cancer	3.47e-06	6.29e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SLC22A1—hematologic cancer	3.43e-06	6.22e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CRABP1—hematologic cancer	3.43e-06	6.22e-05	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PTEN—hematologic cancer	3.43e-06	6.22e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PIK3CB—hematologic cancer	3.42e-06	6.2e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—ESR1—hematologic cancer	3.41e-06	6.19e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—FN1—hematologic cancer	3.37e-06	6.11e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ALOX5—hematologic cancer	3.34e-06	6.06e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—BAD—hematologic cancer	3.33e-06	6.04e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NFKBIA—hematologic cancer	3.33e-06	6.04e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—MTHFR—hematologic cancer	3.33e-06	6.04e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—IDH1—hematologic cancer	3.31e-06	5.99e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	3.3e-06	5.98e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NOTCH1—hematologic cancer	3.3e-06	5.98e-05	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—MYC—hematologic cancer	3.28e-06	5.94e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	3.28e-06	5.94e-05	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—EP300—hematologic cancer	3.27e-06	5.93e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—TXN—hematologic cancer	3.27e-06	5.92e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ABCC3—hematologic cancer	3.27e-06	5.92e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTO1—hematologic cancer	3.27e-06	5.92e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NUP98—hematologic cancer	3.24e-06	5.87e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CD80—hematologic cancer	3.23e-06	5.86e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PIK3CG—hematologic cancer	3.23e-06	5.85e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—KIT—hematologic cancer	3.23e-06	5.85e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SPHK1—hematologic cancer	3.2e-06	5.79e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PTPN11—hematologic cancer	3.17e-06	5.74e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ADCY7—hematologic cancer	3.14e-06	5.7e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NCOA3—hematologic cancer	3.14e-06	5.7e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NUP214—hematologic cancer	3.12e-06	5.66e-05	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—AKT1—hematologic cancer	3.11e-06	5.63e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—MAPK14—hematologic cancer	3.09e-06	5.61e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	3.09e-06	5.6e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—UGT1A1—hematologic cancer	3.07e-06	5.57e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CREB1—hematologic cancer	3.07e-06	5.57e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ABCG2—hematologic cancer	3.06e-06	5.54e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—MTR—hematologic cancer	3.06e-06	5.54e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—ESR1—hematologic cancer	3.04e-06	5.5e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—BRAF—hematologic cancer	3.03e-06	5.5e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	3.01e-06	5.45e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CCL2—hematologic cancer	3.01e-06	5.45e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ENO2—hematologic cancer	3e-06	5.43e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IL6R—hematologic cancer	3e-06	5.43e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CREBBP—hematologic cancer	2.99e-06	5.42e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CRABP1—hematologic cancer	2.99e-06	5.42e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SLC22A1—hematologic cancer	2.99e-06	5.42e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PTEN—hematologic cancer	2.96e-06	5.36e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.94e-06	5.32e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—NOTCH1—hematologic cancer	2.93e-06	5.32e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ALOX5—hematologic cancer	2.91e-06	5.28e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	2.91e-06	5.28e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GSTT1—hematologic cancer	2.91e-06	5.27e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	2.86e-06	5.19e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MAP2K1—hematologic cancer	2.86e-06	5.17e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SDC1—hematologic cancer	2.84e-06	5.15e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PIK3CD—hematologic cancer	2.84e-06	5.14e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NUP98—hematologic cancer	2.82e-06	5.11e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—EP300—hematologic cancer	2.82e-06	5.11e-05	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—MAPK3—hematologic cancer	2.81e-06	5.09e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PIK3CG—hematologic cancer	2.8e-06	5.07e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ADCY7—hematologic cancer	2.74e-06	4.96e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NCOA3—hematologic cancer	2.74e-06	4.96e-05	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—MYC—hematologic cancer	2.73e-06	4.95e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NUP214—hematologic cancer	2.72e-06	4.93e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—FGF2—hematologic cancer	2.72e-06	4.92e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	2.72e-06	4.92e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	2.68e-06	4.86e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PIK3R1—hematologic cancer	2.68e-06	4.85e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ABCG2—hematologic cancer	2.66e-06	4.83e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—MTR—hematologic cancer	2.66e-06	4.83e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—CREBBP—hematologic cancer	2.66e-06	4.82e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ENO2—hematologic cancer	2.61e-06	4.73e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—JAK2—hematologic cancer	2.6e-06	4.72e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CREBBP—hematologic cancer	2.6e-06	4.7e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.56e-06	4.65e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MDM2—hematologic cancer	2.54e-06	4.6e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTT1—hematologic cancer	2.53e-06	4.59e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SDC1—hematologic cancer	2.48e-06	4.49e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MTOR—hematologic cancer	2.47e-06	4.48e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PIK3CB—hematologic cancer	2.47e-06	4.48e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PIK3CD—hematologic cancer	2.46e-06	4.46e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	2.46e-06	4.46e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ALB—hematologic cancer	2.43e-06	4.4e-05	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PIK3CA—hematologic cancer	2.42e-06	4.38e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CD44—hematologic cancer	2.42e-06	4.38e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NQO1—hematologic cancer	2.42e-06	4.38e-05	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.37e-06	4.3e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.37e-06	4.29e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PIK3R1—hematologic cancer	2.32e-06	4.21e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CDKN1B—hematologic cancer	2.32e-06	4.2e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYCS—hematologic cancer	2.29e-06	4.14e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CASP3—hematologic cancer	2.27e-06	4.12e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	2.27e-06	4.12e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IL2—hematologic cancer	2.27e-06	4.11e-05	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	2.22e-06	4.02e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CCND1—hematologic cancer	2.21e-06	4.01e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—JUN—hematologic cancer	2.21e-06	4e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PIK3CB—hematologic cancer	2.15e-06	3.89e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CDKN1A—hematologic cancer	2.14e-06	3.88e-05	CbGpPWpGaD
Spironolactone—AR—Gene Expression—MAPK3—hematologic cancer	2.14e-06	3.88e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PTEN—hematologic cancer	2.14e-06	3.87e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NQO1—hematologic cancer	2.11e-06	3.82e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CD44—hematologic cancer	2.11e-06	3.82e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MAPK8—hematologic cancer	2.09e-06	3.79e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PIK3CA—hematologic cancer	2.09e-06	3.78e-05	CbGpPWpGaD
Spironolactone—AR—Gene Expression—MYC—hematologic cancer	2.08e-06	3.77e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.05e-06	3.71e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—EP300—hematologic cancer	2.04e-06	3.69e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GSTP1—hematologic cancer	2.02e-06	3.65e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYCS—hematologic cancer	1.99e-06	3.61e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—SRC—hematologic cancer	1.98e-06	3.59e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—HSP90AA1—hematologic cancer	1.98e-06	3.59e-05	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—AKT1—hematologic cancer	1.98e-06	3.58e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.95e-06	3.53e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—VEGFA—hematologic cancer	1.93e-06	3.5e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—STAT3—hematologic cancer	1.91e-06	3.46e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ABCB1—hematologic cancer	1.91e-06	3.46e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NRAS—hematologic cancer	1.91e-06	3.45e-05	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—AKT1—hematologic cancer	1.89e-06	3.43e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PTEN—hematologic cancer	1.85e-06	3.36e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NCOR1—hematologic cancer	1.85e-06	3.36e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GSTM1—hematologic cancer	1.85e-06	3.36e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MAPK3—hematologic cancer	1.83e-06	3.31e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MYC—hematologic cancer	1.78e-06	3.22e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TGFB1—hematologic cancer	1.77e-06	3.21e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—EP300—hematologic cancer	1.77e-06	3.2e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTP1—hematologic cancer	1.76e-06	3.18e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—AKT1—hematologic cancer	1.7e-06	3.09e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—KRAS—hematologic cancer	1.64e-06	2.97e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—MTHFR—hematologic cancer	1.64e-06	2.97e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—MAPK3—hematologic cancer	1.62e-06	2.94e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NCOR1—hematologic cancer	1.61e-06	2.92e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTM1—hematologic cancer	1.61e-06	2.92e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—MYC—hematologic cancer	1.58e-06	2.86e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PIK3CA—hematologic cancer	1.51e-06	2.73e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TP53—hematologic cancer	1.46e-06	2.64e-05	CbGpPWpGaD
Spironolactone—AR—Gene Expression—AKT1—hematologic cancer	1.44e-06	2.61e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.44e-06	2.61e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—MTHFR—hematologic cancer	1.43e-06	2.58e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HRAS—hematologic cancer	1.39e-06	2.53e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PIK3CG—hematologic cancer	1.38e-06	2.49e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IL6—hematologic cancer	1.34e-06	2.42e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PIK3CA—hematologic cancer	1.31e-06	2.37e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CREBBP—hematologic cancer	1.28e-06	2.31e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—AKT1—hematologic cancer	1.23e-06	2.23e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PIK3CD—hematologic cancer	1.21e-06	2.19e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PIK3CG—hematologic cancer	1.2e-06	2.17e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ALB—hematologic cancer	1.19e-06	2.16e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PIK3R1—hematologic cancer	1.14e-06	2.07e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CREBBP—hematologic cancer	1.11e-06	2.01e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—AKT1—hematologic cancer	1.09e-06	1.98e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—AKT1—hematologic cancer	1.07e-06	1.94e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PIK3CB—hematologic cancer	1.05e-06	1.91e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PIK3CD—hematologic cancer	1.05e-06	1.91e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ALB—hematologic cancer	1.04e-06	1.88e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PIK3R1—hematologic cancer	9.95e-07	1.8e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PIK3CB—hematologic cancer	9.18e-07	1.66e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PTEN—hematologic cancer	9.11e-07	1.65e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—EP300—hematologic cancer	8.69e-07	1.57e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PTEN—hematologic cancer	7.94e-07	1.44e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—EP300—hematologic cancer	7.57e-07	1.37e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PIK3CA—hematologic cancer	6.43e-07	1.16e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PIK3CA—hematologic cancer	5.6e-07	1.01e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—AKT1—hematologic cancer	5.25e-07	9.51e-06	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—AKT1—hematologic cancer	4.57e-07	8.29e-06	CbGpPWpGaD
